Cancer microenvironment

The advent of immune checkpoint inhibition therapies has fundamentally changed the care pathway of cancer patients giving hope for cure in previously deadly diseases. Despite this, a considerable portion of patients do not benefit from these treatments and we need to understand better the complex interplay between immune cells and cancer cells to offer better treatment solutions. In this project, we investigate the complexity of cancer microenvironment from the perspective of patient survival in both, an untreated setting as well as in the context of response to therapies.